These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 17715981)

  • 1. Functional aptamers and aptazymes in biotechnology, diagnostics, and therapy.
    Famulok M; Hartig JS; Mayer G
    Chem Rev; 2007 Sep; 107(9):3715-43. PubMed ID: 17715981
    [No Abstract]   [Full Text] [Related]  

  • 2. Aptamers: a promising tool for cancer imaging, diagnosis, and therapy.
    Liu K; Lin B; Lan X
    J Cell Biochem; 2013 Feb; 114(2):250-5. PubMed ID: 22949372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.
    Pangburn TO; Petersen MA; Waybrant B; Adil MM; Kokkoli E
    J Biomech Eng; 2009 Jul; 131(7):074005. PubMed ID: 19655996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outlook for aptamers after twenty five years.
    Tsae PK; DeRosa MC
    Curr Top Med Chem; 2015; 15(12):1153-9. PubMed ID: 25910491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aptamers in targeted nanotherapy.
    Mathew A; Maekawa T; Sakthikumar D
    Curr Top Med Chem; 2015; 15(12):1102-14. PubMed ID: 25866269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Easy design of logic gates based on aptazymes and noncrosslinking gold nanoparticle aggregation.
    Ogawa A; Maeda M
    Chem Commun (Camb); 2009 Aug; (31):4666-8. PubMed ID: 19641803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Peptide aptamers and nano-carriers for cancer therapy].
    Shiba K
    Gan To Kagaku Ryoho; 2009 Mar; 36(3):362-5. PubMed ID: 19295259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aptamers come of age - at last.
    Bunka DH; Stockley PG
    Nat Rev Microbiol; 2006 Aug; 4(8):588-96. PubMed ID: 16845429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aptamers: turning the spotlight on cells.
    López-Colón D; Jiménez E; You M; Gulbakan B; Tan W
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(3):328-40. PubMed ID: 21412992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aptamers--new type of reagents to research, diagnostics and treatment].
    Kemp M; Christensen JJ; Kolmos HJ; Andresen K
    Ugeskr Laeger; 2007 Mar; 169(12):1136. PubMed ID: 17394847
    [No Abstract]   [Full Text] [Related]  

  • 11. Aptamers--basic research, drug development, and clinical applications.
    Proske D; Blank M; Buhmann R; Resch A
    Appl Microbiol Biotechnol; 2005 Dec; 69(4):367-74. PubMed ID: 16283295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotechnology and aptamers: applications in drug delivery.
    Levy-Nissenbaum E; Radovic-Moreno AF; Wang AZ; Langer R; Farokhzad OC
    Trends Biotechnol; 2008 Aug; 26(8):442-9. PubMed ID: 18571753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development and testing of aptamers for cancer.
    Barbas AS; White RR
    Curr Opin Investig Drugs; 2009 Jun; 10(6):572-8. PubMed ID: 19513946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial ribozyme switches containing natural riboswitch aptamer domains.
    Wieland M; Benz A; Klauser B; Hartig JS
    Angew Chem Int Ed Engl; 2009; 48(15):2715-8. PubMed ID: 19156802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aptamers: active targeting ligands for cancer diagnosis and therapy.
    Wu X; Chen J; Wu M; Zhao JX
    Theranostics; 2015; 5(4):322-44. PubMed ID: 25699094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric aptamers and aptazymes as probes for screening approaches.
    Famulok M
    Curr Opin Mol Ther; 2005 Apr; 7(2):137-43. PubMed ID: 15844621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex target SELEX.
    Shamah SM; Healy JM; Cload ST
    Acc Chem Res; 2008 Jan; 41(1):130-8. PubMed ID: 18193823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aptamers and in-beam PET for advanced diagnosis and therapy optimisation.
    Lucignani G
    Eur J Nucl Med Mol Imaging; 2006 Sep; 33(9):1095-7. PubMed ID: 16896657
    [No Abstract]   [Full Text] [Related]  

  • 19. Selection of thioaptamers for diagnostics and therapeutics.
    Yang X; Wang H; Beasley DW; Volk DE; Zhao X; Luxon BA; Lomas LO; Herzog NK; Aronson JF; Barrett AD; Leary JF; Gorenstein DG
    Ann N Y Acad Sci; 2006 Oct; 1082():116-9. PubMed ID: 17145932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemical biology of aptamers.
    Mayer G
    Angew Chem Int Ed Engl; 2009; 48(15):2672-89. PubMed ID: 19319884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.